These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11020006)

  • 41. Current and prospective pharmacotherapy for autoimmune hepatitis.
    Czaja AJ
    Expert Opin Pharmacother; 2014 Aug; 15(12):1715-36. PubMed ID: 24961409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
    Daikeler T
    Swiss Med Wkly; 2009 Jan; 139(3-4):34. PubMed ID: 19169900
    [No Abstract]   [Full Text] [Related]  

  • 43. Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil.
    Quirós-Tejeira RE; Ament ME; Vargas JH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):482-5. PubMed ID: 12658040
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of autoimmune hepatitis.
    Mayo MJ
    Curr Opin Gastroenterol; 2011 May; 27(3):224-30. PubMed ID: 21451411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver function tests in mycophenolate mofetil-treated hepatitis C virus-positive kidney allograft recipients.
    Ribeiro AR; Veronese FV; Manfro RC; Gonçalves LF
    Transplant Proc; 2002 Mar; 34(2):489-90. PubMed ID: 12009600
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treating chronic severe hepatitis B patients with mycophenolate mofetil].
    Yang YF; Tan DM; Xie YT; Lu MH; Liu ZB; Sha XP; Liu GZ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):392-3. PubMed ID: 15918985
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B.
    Maes BD; van Pelt JF; Peeters JC; Nevens F; Evenepoel P; Kuypers D; Messiaen T; Fevery J; Vanrenterghem YF
    Transplantation; 2001 Sep; 72(6):1165-6. PubMed ID: 11579320
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs: 9. Mycophenolate mofetil].
    Kono M; Atsumi T
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2954-9. PubMed ID: 22175137
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil.
    Goyal S; Nousari HC
    J Am Acad Dermatol; 2001 Jul; 45(1):142-4. PubMed ID: 11423853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
    Lankarani KB
    Aliment Pharmacol Ther; 2005 May; 21(10):1279-80; author reply 1280. PubMed ID: 15882250
    [No Abstract]   [Full Text] [Related]  

  • 51. Should MMF treatment be the first-line therapy in autoimmune hepatitis?
    Alric L
    J Hepatol; 2024 Jul; 81(1):e40. PubMed ID: 38403032
    [No Abstract]   [Full Text] [Related]  

  • 52. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
    Zimmer-Molsberger B; Knauf W; Thiel E
    Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
    [No Abstract]   [Full Text] [Related]  

  • 53. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.
    Talhari C; Mahnke N; Ruzicka T; Megahed M
    Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696
    [No Abstract]   [Full Text] [Related]  

  • 54. Mycophenolate mofetil in IgA nephropathy.
    Sepe V; Rossi N; Adamo G; Dal Canton A
    Kidney Int; 2004 Oct; 66(4):1713; author reply 1713-4. PubMed ID: 15458475
    [No Abstract]   [Full Text] [Related]  

  • 55. Mycophenolate mofetil.
    Heymann WR
    J Am Acad Dermatol; 2005 Dec; 53(6):1045-6. PubMed ID: 16310066
    [No Abstract]   [Full Text] [Related]  

  • 56. Mycophenolate mofetil therapy.
    Kilmartin DJ; Dick AD
    Ophthalmology; 1999 Sep; 106(9):1645. PubMed ID: 10485526
    [No Abstract]   [Full Text] [Related]  

  • 57. Mycophenolate mofetil for psoriasis.
    Kirby B; Yates VM
    Br J Dermatol; 1998 Aug; 139(2):357. PubMed ID: 9767269
    [No Abstract]   [Full Text] [Related]  

  • 58. Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection.
    Caponnetto C; Rossi E; Primavera A
    Eur Neurol; 2001; 46(1):53-4. PubMed ID: 11455187
    [No Abstract]   [Full Text] [Related]  

  • 59. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients.
    Johnson DW; Nicol DL; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM
    Transplantation; 2003 Aug; 76(3):619. PubMed ID: 12923455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.